<!DOCTYPE html>
<html lang="en" style="--theme-color: #262626; --link-color: #262626;">
<head>
  <meta charset="UTF-8">
  <title>医学翻译学习-抗CD4抗体UB-421对治疗中断后HIV-1反弹的效应 - 王楠鑫|Curtis_一个医学译者的前后左右</title>

  <link rel="icon" href="">
<!-- <link href="https://cdn.jsdelivr.net/npm/remixicon@2.5.0/fonts/remixicon.css" rel="stylesheet"> -->
<link rel="alternate" type="application/atom+xml" title="王楠鑫|Curtis_一个医学译者的前后左右 - Atom Feed" href="https://airmedtrans.com/atom.xml">

  

  
  <!-- Global site tag (gtag.js) - Google Analytics -->
  <!-- <script async src="https://www.googletagmanager.com/gtag/js?id=G-NFCRR8Q57W"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);}
    gtag('js', new Date());
  </script> -->
  <script async src='https://www.google-analytics.com/analytics.js'></script>



  <script>
    window.ga=window.ga||function(){(ga.q=ga.q||[]).push(arguments)};ga.l=+new Date;
    ga('create', 'UA-182385326-1');
    ga('set', 'dimension1', 'site/cbS9tMKNT');
    ga('set', 'dimension2', 'post/L_dz7kIOd');
    ga('send', 'pageview');
    // gtag('set', {
    //   'custom_map': {
    //     'dimension1': 'siteId',
    //     'dimension2': 'postId',
    //   }
    // })

    // gtag('config', 'G-NFCRR8Q57W', {
    //   'siteId': 'site/cbS9tMKNT',
    //   'postId': 'post/L_dz7kIOd',
    // });
  </script>





  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="description" content="关于“抗CD4抗体UB-421对治疗中断后HIV-1反弹的效应”一文医学翻译摘要学习情况，记录于此。
 Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment ...">

  <meta property="og:title" content="医学翻译学习-抗CD4抗体UB-421对治疗中断后HIV-1反弹的效应 - 王楠鑫|Curtis_一个医学译者的前后左右">
  <meta property="og:description" content="关于“抗CD4抗体UB-421对治疗中断后HIV-1反弹的效应”一文医学翻译摘要学习情况，记录于此。
 Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment ...">
  
  <meta property="og:url" content="https://airmedtrans.com/UTAFdLN7l/">
  <meta property="og:site_name" content="王楠鑫|Curtis_一个医学译者的前后左右">

  <meta name="twitter:card" content="summary_large_image">
  <meta name="twitter:image:alt" content="医学翻译学习-抗CD4抗体UB-421对治疗中断后HIV-1反弹的效应">

  <meta name="gridea:post_id" content="L_dz7kIOd">

  <link rel="canonical" href="https://airmedtrans.com/UTAFdLN7l">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/highlight.js@10.0.3/styles/a11y-light.css">
  
  <link rel="stylesheet" href="//cdn.jsdelivr.net/npm/@gridea/theme@1.0.8/css/main.css">

</head>
<body>
  
    
  
  <div id="page">
    <div class="mb-16 sticky top-0 z-20 bg-white">
  <header class="py-4 flex items-baseline justify-between max-w-2xl mx-auto px-2">
    <h1 class="text-lg text-center font-medium px-4 md:px-0 flex items-center">
      <div class="site-logo-text font-normal">王</div>
      <a href="/">王楠鑫|Curtis_一个医学译者的前后左右</a>
    </h1>
    <div class="hidden sm:flex justify-center">
      
        
        <a
          href="https://airmedtrans.com/aboutme"
          class="mx-2 text-base border-b border-transparent"
          target="_blank"
        >关于我</a>
        
          <span class="text-gray-200">/</span>
        
      
        
        <a
          href="https://airmedtrans.com/contact me"
          class="mx-2 text-base border-b border-transparent"
          target="_blank"
        >联系我</a>
        
      
    </div>
    <div class="flex sm:hidden py-2 px-4 text-center cursor-pointer" @click="openMenu = true">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="24" height="24"><path fill="none" d="M0 0h24v24H0z"/><path d="M3 4h18v2H3V4zm0 7h18v2H3v-2zm0 7h18v2H3v-2z"/></svg>
    </div>
  </header>

  <div class="fixed top-0 right-0 bottom-0 left-0 bg-white hidden" :style="{
    display: openMenu ? 'block !important' : 'none',
  }" v-if="openMenu">
    <div class="py-4 px-2 flex justify-end" @click="openMenu = false">
      <div class="flex py-2 px-4 text-center cursor-pointer">
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="24" height="24"><path fill="none" d="M0 0h24v24H0z"/><path d="M12 10.586l4.95-4.95 1.414 1.414-4.95 4.95 4.95 4.95-1.414 1.414-4.95-4.95-4.95 4.95-1.414-1.414 4.95-4.95-4.95-4.95L7.05 5.636z"/></svg>
      </div>
    </div>
    <div class="flex flex-col p-4">
      
        
        <a
          href="https://airmedtrans.com/aboutme"
          class="mx-2 my-4 text-base border-b border-transparent"
          target="_blank"
        >关于我</a>
      
        
        <a
          href="https://airmedtrans.com/contact me"
          class="mx-2 my-4 text-base border-b border-transparent"
          target="_blank"
        >联系我</a>
      
    </div>
  </div>
</div>
    <div class="border-b border-gray-200">
      <div class="max-w-2xl mx-auto px-6 md:px-2">
        <div class="my-24 text-center">
          <h1 class="text-2xl font-bold">医学翻译学习-抗CD4抗体UB-421对治疗中断后HIV-1反弹的效应</h1>
          <div class="post-title-bar mx-auto rounded mt-4"></div>
          <div class="text-gray-400 mt-4">2020.10.16</div>
          <div class="flex justify-center mt-4">
            
          </div>
        </div>
      </div>
    </div>
    <div id="sticky-bar" class="w-full sticky top-0 z-10 bg-white" style="height: 64px;"></div>
    <div class="p-4 md:p-16 bg-white">
      <div class="max-w-2xl mx-auto px-4 flex relative">
        <section class="post-content flex-1 default-post-content max-w-2xl">
          <div v-pre>
            <p>关于“抗CD4抗体UB-421对治疗中断后HIV-1反弹的效应”一文医学翻译摘要学习情况，记录于此。</p>
<p><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa1802264?query=nejmyxqy"> Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption</a></p>
<!--more-->
<hr>
<blockquote>
<p><strong>背景</strong></p>
<p>BACKGROUND</p>
<p>在人类免疫缺陷病毒（HIV）感染者未接受抗逆转录病毒治疗（ART）的情况下，单独给予广泛中和HIV特异性抗体会导致耐抗体病毒的产生。</p>
<p>Administration of a single broadly neutralizing human immunodeficiency virus (HIV)–specific antibody to HIV-infected persons leads to the development of antibody-resistant virus in the absence of antiretroviral therapy (ART).</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>development vs 产生</li>
<li>In the absense of</li>
</ul>
<blockquote>
<p>在实施分析性治疗中断（analytic treatment interruption）的HIV感染者中，UB-421（阻断人CD4+ T细胞上病毒结合位点的抗体）有可能诱导持续的病毒学抑制，且不会诱导耐药。</p>
<p>It is possible that monotherapy with UB-421, an antibody that blocks the virus-binding site on human CD4+ T cells, could induce sustained virologic suppression without induction of resistance in HIV-infected persons after analytic treatment interruption.</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>virus-binding site	病毒结合位点</li>
<li>analytic treatment interruption	分析性治疗中断</li>
<li>without induction of resistance	不会诱导耐药</li>
<li>monotherapy 省略了....可惜我没有这个魄力</li>
</ul>
<blockquote>
<p><strong>方法</strong></p>
<p>Methods</p>
<p>我们开展了一项非随机、开放标签、2期临床研究，在实施分析性治疗中断的HIV感染者中评价了UB-421单药治疗的安全性、药代动力学和抗病毒活性。</p>
<p>We conducted a nonrandomized, open-label, phase 2 clinical study evaluating the safety, pharmacokinetics, and antiviral activity of UB-421 monotherapy in HIV-infected persons undergoing analytic treatment interruption.</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>虽然有人用open-labelled，但实际上，open-label最常用</li>
<li>整体结构属于套路</li>
</ul>
<blockquote>
<p>筛选访视时，所有参与者的血浆病毒均不可测（＜20 copies HIV RNA/mL）。</p>
<p>All the participants had undetectable plasma viremia (&lt;20 copies of HIV RNA per milliliter) at the screening visit.</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>the screening visit	筛选访视</li>
</ul>
<blockquote>
<p>停用ART后，参与者接受了8次UB-421静脉输入，剂量为每周1次，每次10 mg/kg（队列1），或者每2周1次，每次25 mg/kg（队列2）。</p>
<p>After discontinuation of ART, participants received eight intravenous infusions of UB-421, at a dose of either 10 mg per kilogram of body weight every week (Cohort 1) or 25 mg per kilogram every 2 weeks (Cohort 2).</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>kilogram of body weight	翻译到英文时，常常会漏掉</li>
<li>either or 这个结构其实也挺有意思的</li>
</ul>
<blockquote>
<p>主要结局是至病毒反弹（≥400 copies/mL）的时间。</p>
<p>The primary outcome was the time to viral rebound (≥400 copies per milliliter).</p>
</blockquote>
<blockquote>
<p><strong>结果</strong></p>
<p>RESULTS</p>
<p>本研究共纳入29例参与者，队列1中14例，队列2中15例。</p>
<p>A total of 29 participants were enrolled, 14 in Cohort 1 and 15 in Cohort 2.</p>
</blockquote>
<blockquote>
<p>在分析性治疗中断期间，UB-421对于所有参与者（研究访视2～9中94.5%的测定值）均维持了病毒学抑制（＜20 copies/mL），在8例参与者（28%）中观察到间歇性病毒载量一过性小幅反弹（viral blip）（范围，21～142 copies/mL）。</p>
<p>Administration of UB-421 maintained virologic suppression (&lt;20 copies per milliliter) in all the participants (94.5% of measurements at study visits 2 through 9) during analytic treatment interruption, with intermittent viral blips (range, 21 to 142 copies per milliliter) observed in 8 participants (28%).</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>维持病毒学抑制	maintain virologic suppression</li>
</ul>
<blockquote>
<p>没有任何参与者的血浆病毒反弹至超过400 copies/mL。</p>
<p>No study participants had plasma viral rebound to more than 400 copies per milliliter.</p>
</blockquote>
<blockquote>
<p>CD4+ T细胞计数在整个研究期间保持稳定。</p>
<p>CD4+ T-cell counts remained stable throughout the duration of the study.</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>the duration of the study</li>
</ul>
<blockquote>
<p>皮疹（大部分为1级）是常见的一过性不良事件；1例参与者因皮疹停用研究药物。</p>
<p>Rash, mostly of grade 1, was a common and transient adverse event; one participant discontinued the study drug owing to a rash.</p>
</blockquote>
<p>笔记：</p>
<ul>
<li>transient 和上文的 intermittent 都处理未一过性</li>
</ul>
<blockquote>
<p>在UB-421单药治疗期间观察到CD4+调节T细胞群减少。</p>
<p>A decrease in the population of CD4+ regulatory T cells was observed during UB-421 monotherapy.</p>
</blockquote>
<blockquote>
<p><strong>结论</strong></p>
<p>Conclusions</p>
</blockquote>
<blockquote>
<p>在参与者未接受ART的情况下，UB-421（在研究的8～16周）维持了病毒学抑制。</p>
<p>UB-421 maintained virologic suppression (during the 8 to 16 weeks of study) in participants in the absence of ART.</p>
</blockquote>
<blockquote>
<p>1例参与者因皮疹停止治疗（由United Biomedical等资助；在ClinicalTrials.gov注册号为NCT02369146）。</p>
<p>One participant discontinued therapy owing to a rash. (Funded by United Biomedical and others; ClinicalTrials.gov number, <a href="http://clinicaltrials.gov/show/NCT02369146">NCT02369146</a>.)</p>
</blockquote>

          </div>
          <div class="py-4 text-gray-600 flex items-center justify-between">
            <div class="">
              <div class="text-sm text-gray-300">最后更新于: </div>
              <div class="text-base font-medium">2020.10.16</div>
            </div>
            <!-- <div class="flex items-center text-sm text-gray-600">
              <i class="ri-eye-line"></i> <span class="ml-2">{{ views }}</span>
            </div> -->
          </div>
          <div>
            <div id="disqus_thread"></div>
          </div>
        </section>
        
      </div>
    </div>
    <div class="py-8 text-gray-300 text-center border-t border-gray-200">
  Powered by Gridea
</div>
  </div>

  <script src="//cdn.jsdelivr.net/npm/vue@2.6.11"></script>
  
  <script src="//cdn.jsdelivr.net/npm/@gridea/theme@1.0.8/js/main.js"></script>

  <script src="//cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.0.0/build/highlight.min.js"></script>
  <script>hljs.initHighlightingOnLoad();</script>
  
    <script>

/**
*  RECOMMENDED CONFIGURATION VARIABLES: EDIT AND UNCOMMENT THE SECTION BELOW TO INSERT DYNAMIC VALUES FROM YOUR PLATFORM OR CMS.
*  LEARN WHY DEFINING THESE VARIABLES IS IMPORTANT: https://disqus.com/admin/universalcode/#configuration-variables*/
/*
var disqus_config = function () {
this.page.url = PAGE_URL;  // Replace PAGE_URL with your page's canonical URL variable
this.page.identifier = PAGE_IDENTIFIER; // Replace PAGE_IDENTIFIER with your page's unique identifier variable
};
*/
(function() { // DON'T EDIT BELOW THIS LINE
var d = document, s = d.createElement('script');
s.src = 'https://airmedtrans-com.disqus.com/embed.js';
s.setAttribute('data-timestamp', +new Date());
(d.head || d.body).appendChild(s);
})();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
                            
  
  
    
  
</body>
</html>